FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1484011000168106: varicella-zoster virus glycoprotein E recombinant adjuvanted antigen 50 microgram injection, 50 microgram vial (medicinal product unit of use)


Status: current, Defined. Date: 31-Jul 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4432841000168113 varicella-zoster virus glycoprotein E recombinant adjuvanted antigen 50 microgram injection, 50 microgram vial (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4432851000168110 varicella-zoster virus glycoprotein E recombinant adjuvanted antigen 50 microgram injection, vial en Synonym Active Case sensitive Australian Medicines Terminology module
4432981000168114 varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial en Synonym Active Case sensitive Australian Medicines Terminology module
4432991000168112 zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial Is a varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine true Inferred relationship Some
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial Is a medicinal product unit of use true Inferred relationship Some
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial has manufactured dose form injection true Inferred relationship Some
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial has unit of use vial true Inferred relationship Some 1349529417
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial has Australian BoSS varicella-zoster virus glycoprotein E recombinant adjuvanted antigen true Inferred relationship Some 1400961895
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial has intended active ingredient varicella-zoster virus glycoprotein E recombinant adjuvanted antigen true Inferred relationship Some 1400961895

Inbound Relationships Type Active Source Characteristic Refinability Group
Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial Is a True varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial Inferred relationship Some
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack has MPUU True varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial Inferred relationship Some 1468090660
varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL vials], 1 pack has MPUU True varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial Inferred relationship Some 2100027147

Reference Sets

Vaccine reference set

List of Excluded Medicinal Items reference set

Medicinal product unit of use reference set

Back to Start